Peter Greenleaf Insider Profile

4 Followers
Peter Greenleaf

Peter Greenleaf
Sucampo Pharmaceuticals (SCMP)
CEO

Ranked #26,655 out of 102,028 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+17.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$759K
59.30%
40.70%
0.00%
0.00%
0.00% Others
A breakdown of Peter Greenleaf's holdings

Insider Roles

Avalo Therapeutics
(AVTX)
Director
Aurinia Pharmaceuticals
(AUPH)
CEO, Director
Synlogic
(SYBX)
Director
Cerecor Inc
(CERCU)
Director
+1 other positions
Roles that Peter Greenleaf holds in companies

Most Profitable Insider Trade

Stock:
Avalo Therapeutics
(AVTX)
Rating:Informative Buy
Date:May 21, 2018 - May 21, 2019
Return:+41.30%
The most profitable trade made by Peter Greenleaf

Peter Greenleaf's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
Uninformative Sell
$2.34M
$0.00
Synlogic
Director
Cerecor Inc
Director
Avalo Therapeutics
May 29, 2019
Director
Uninformative Sell
$450.00K
BDSI
BioDelivery
Mar 22, 2022
Uninformative Sell
$0.00
Kiora Pharmaceuticals
Director
ATRS
Antares Pharma
Jun 14, 2021
Uninformative Buy
$112.50K
$445.22K
Aurinia Pharmaceuticals
Mar 04, 2022
CEO, Director
Uninformative Buy
$308.90K
List of latest transactions for each holding click on a transaction to see Peter Greenleaf's performance on stock

Peter Greenleaf insider profile FAQ

What is the percentage of profitable transactions made by Peter Greenleaf?
The percentage of profitable transactions made by Peter Greenleaf is 75%.
    What is the average return per transaction made by Peter Greenleaf?
    The average return per transaction made by Peter Greenleaf is 17.00%.
      What stocks does Peter Greenleaf hold?
      Peter Greenleaf holds: SCMP, SYBX, CERCU, AVTX, BDSI, KPRX, ATRS, AUPH stocks.
        What was Peter Greenleaf’s latest transaction?
        Peter Greenleaf latest transaction was an Uninformative Sell of $2.34M.
          What was Peter Greenleaf's most profitable transaction?
          Peter Greenleaf’s most profitable transaction was an Informative Buy of AVTX stock on May 21, 2018. The return on the trade was 41.30%.
            What is Peter Greenleaf's role in Sucampo Pharmaceuticals?
            Peter Greenleaf's role in Sucampo Pharmaceuticals is CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.